Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy

Some antiepileptic drugs (AEDS), like sodium channel blockers are significantly associated with autonomic dysfunction in patients with epilepsy. Unlike other sodium-blockers AEDs, lacosamide (LCM) is a third generation AEDs which enhances the slow inactivation of voltage-gated sodium channels. So far, data about LCM on autonomic nervous system are still unknown. This study was designed to investigate cardiovascular autonomic and sudomotor function in patients affected by focal epilepsy on LCM monotherapy, compared to patients treated with carbamazepine (CBZ) monotherapy and healthy subjects.

Source link

Related posts

New Alzheimer’s target treatment may save brain cells


FDA to Review Treatment for Jet Lag Disorder


The Dyslexic Brain: Variability in Natural Speech is Challenging


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World